{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:25Z","timestamp":1791316705055,"version":"4.3.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Municipal Health Commission Scientific Research Project","award":["20244Y0111"],"award-info":[{"award-number":["20244Y0111"]}]},{"name":"a grant of National Key Research and Development Program of China","award":["2022YFF0705300"],"award-info":[{"award-number":["2022YFF0705300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52272281"],"award-info":[{"award-number":["52272281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["2021SHZDZX0100"],"award-info":[{"award-number":["2021SHZDZX0100"]}]},{"name":"the Fundamental Research Funds for the Central Universities, Shanghai Municipal Health Commission Health Industry Clinical Research Project, Clinical Research Project of Shanghai Pulmonary Hospital","award":["FKLY20010"],"award-info":[{"award-number":["FKLY20010"]}]},{"name":"Young Talents in Shanghai","award":["2019 QNBJ"],"award-info":[{"award-number":["2019 QNBJ"]}]},{"name":"2021 Science and Technology Think Tank Youth Talent Plan of China Association for Science and Technology, National Key Research and Development Program of China","award":["2021YFF1201200"],"award-info":[{"award-number":["2021YFF1201200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04835-7","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:48:08Z","timestamp":1775447288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Maoying","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-6390","authenticated-orcid":false,"given":"Hongbin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-9119","authenticated-orcid":false,"given":"Yayi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"1","key":"4835_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4835_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s44178-024-00069-w","volume":"3","author":"J Wang","year":"2024","unstructured":"Wang J, Association SOLC. Caca guidelines for holistic integrative management of lung cancer. Holistic Integrative Oncology. 2024;3(1):10.","journal-title":"Holistic Integrative Oncology"},{"issue":"12","key":"4835_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrc.2017.87","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):725\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"4835_CR4","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2025.0560","volume":"333","author":"SY Kim","year":"2025","unstructured":"Kim SY, Park HS, Chiang AC. Small cell lung cancer: a review. JAMA. 2025;333(21):1906\u201317.","journal-title":"JAMA"},{"issue":"1","key":"4835_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4835_CR6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013122","volume":"13","author":"J Ko","year":"2021","unstructured":"Ko J, Winslow MM, Sage J. Mechanisms of small cell lung cancer metastasis. EMBO Mol Med. 2021;13(1):e13122.","journal-title":"EMBO Mol Med"},{"issue":"10212","key":"4835_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","volume":"394","author":"L Paz-Ares","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (caspian): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019;394(10212):1929\u201339.","journal-title":"Lancet"},{"issue":"15","key":"4835_CR8","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","volume":"27","author":"PNJ Lara","year":"2009","unstructured":"Lara PNJ, Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, et al. Phase III trial of irinotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG s0124. J Clin Oncol. 2009;27(15):2530\u20135.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4835_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1200\/JCO.21.01881","volume":"40","author":"J Zugazagoitia","year":"2022","unstructured":"Zugazagoitia J, Paz-Ares L. Extensive-stage small-cell lung cancer: first-line and second-line treatment options. J Clin Oncol. 2022;40(6):671\u201380.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4835_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s44178-026-00235-2","volume":"5","author":"X Liu","year":"2026","unstructured":"Liu X, Kuang L, Wu L, Li Y. High throughput sequencing in oncology: from tumor characterization to novel therapies. Holist Integr Oncol. 2026;5(1):16.","journal-title":"Holist Integr Oncol"},{"issue":"1","key":"4835_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41416-020-0845-3","volume":"123","author":"F Gelsomino","year":"2020","unstructured":"Gelsomino F, Tiseo M, Barbieri F, Riccardi F, Cavanna L, Frassoldati A, et al. Phase 2 study of NAB-paclitaxel in sensitive and refractory relapsed small cell lung cancer (SCLC) (NABSTER trial). Br J Cancer. 2020;123(1):26\u201332.","journal-title":"Br J Cancer"},{"issue":"5","key":"4835_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s43018-022-00358-1","volume":"3","author":"C Guo","year":"2022","unstructured":"Guo C, Wan R, He Y, Lin S, Cao J, Qiu Y, et al. Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer. Nat Cancer. 2022;3(5):614\u201328.","journal-title":"Nat Cancer"},{"issue":"5","key":"4835_CR13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14642","volume":"28","author":"H Lv","year":"2024","unstructured":"Lv H, Hong Y, Zhang Y, Li S, Li B, Zhang M. Efficacy and safety of nanoparticle albumin\u2011bound paclitaxel compared with solvent\u2011based paclitaxel in adjuvant therapy for breast cancer: a retrospective study. Oncol Lett. 2024;28(5):509.","journal-title":"Oncol Lett"},{"issue":"1","key":"4835_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s44178-025-00202-3","volume":"4","author":"N Fukuba","year":"2025","unstructured":"Fukuba N, Moriyama I, Onoe M, Kodama Y, Kotani S, Oka A, et al. Phase Ib\/II safety study of MK615 in combination with gemcitabine + nab-paclitaxel for unresectable\/recurrent pancreatic cancer. Holistic Integrative Oncology. 2025;4(1):66.","journal-title":"Holistic Integrative Oncology"},{"issue":"1","key":"4835_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3892\/mco.2016.887","volume":"5","author":"H Yoshida","year":"2016","unstructured":"Yoshida H, Kim YH, Ozasa H, Nagai H, Sakamori Y, Nakaoku T, et al. Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer. Mol Clin Oncol. 2016;5(1):213\u20135.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"4835_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","volume":"38","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Micinski AM, Kastner DW, Guo B, Wait SJ, Spainhower KB, et al. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell. 2020;38(1):60\u201378.","journal-title":"Cancer Cell"},{"issue":"17","key":"4835_CR17","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-015-0484-9","volume":"75","author":"HA Blair","year":"2015","unstructured":"Blair HA, Deeks ED. Albumin-bound paclitaxel: a review in non-small cell lung cancer. Drugs. 2015;75(17):2017\u201324.","journal-title":"Drugs"},{"issue":"Suppl 6","key":"4835_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.9-90006-4","volume":"9","author":"A Ardizzoni","year":"2004","unstructured":"Ardizzoni A. Topotecan in the treatment of recurrent small cell lung cancer: an update. Oncologist. 2004;9(Suppl 6):4\u201313.","journal-title":"Oncologist"},{"issue":"2","key":"4835_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","volume":"17","author":"J von Pawel","year":"1999","unstructured":"von Pawel J, Schiller JH, Shepherd FA, Fields SZ, Kleisbauer JP, Chrysson NG, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol. 1999;17(2):658\u201367.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4835_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1200\/JCO.1992.10.8.1225","volume":"10","author":"N Masuda","year":"1992","unstructured":"Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, et al. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol. 1992;10(8):1225\u20139.","journal-title":"J Clin Oncol"},{"issue":"1B","key":"4835_CR21","first-page":"777","volume":"26","author":"N Yamamoto","year":"2006","unstructured":"Yamamoto N, Tsurutani J, Yoshimura N, Asai G, Moriyama A, Nakagawa K, et al. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer. Anticancer Res. 2006;26(1B):777\u201381.","journal-title":"Anticancer Res"},{"issue":"Suppl 2","key":"4835_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.2189","volume":"34","author":"JS Russo-Cabrera","year":"2023","unstructured":"Russo-Cabrera JS, ASCP. Sensitization to immunotherapy through manipulation of tumor transcription by lurbinectedin. Ann Oncol. 2023;34(Suppl 2):S636.","journal-title":"Ann Oncol"},{"issue":"5","key":"4835_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.annonc.2021.01.071","volume":"32","author":"DR Spigel","year":"2021","unstructured":"Spigel DR, Vicente D, Ciuleanu TE, Gettinger S, Peters S, Horn L, et al. Second-line nivolumab in relapsed small-cell lung cancer: checkmate 331. Ann Oncol. 2021;32(5):631\u201341.","journal-title":"Ann Oncol"},{"issue":"9","key":"4835_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014758","volume":"98","author":"K Sugiyama","year":"2019","unstructured":"Sugiyama K, Kogure Y, Torii A, Shiraishi K, Yamada A, Ishida A, et al. Solvent-based paclitaxel or nab-paclitaxel for heavily treated relapsed\/refractory small cell lung cancer: retrospective single-institution observational study. Medicine (Baltimore). 2019;98(9):e14758.","journal-title":"Medicine (Baltimore)"},{"issue":"35","key":"4835_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007884","volume":"96","author":"Y Naito","year":"2017","unstructured":"Naito Y, Tamiya A, Tamiya M, Kimura Y, Hamaguchi M, Saijo N, et al. Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: a retrospective analysis. Medicine (Baltimore). 2017;96(35):e7884.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"4835_CR26","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.21873\/anticanres.14105","volume":"40","author":"M Nakao","year":"2020","unstructured":"Nakao M, Fujita K, Suzuki Y, Arakawa S, Sakai Y, Sato H, et al. Nab-paclitaxel monotherapy for relapsed small cell lung cancer: retrospective analysis and review. Anticancer Res. 2020;40(3):1579\u201385.","journal-title":"Anticancer Res"},{"issue":"12","key":"4835_CR27","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","volume":"16","author":"BH Herzog","year":"2021","unstructured":"Herzog BH, Devarakonda S, Govindan R. Overcoming chemotherapy resistance in SCLC. J Thorac Oncol. 2021;16(12):2002\u201315.","journal-title":"J Thorac Oncol"},{"issue":"15","key":"4835_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35265","volume":"10","author":"L Wei","year":"2024","unstructured":"Wei L. Pan-cancer analysis reveals GGPS1 plays an important role in tumorigenesis in multiple tumor types. Heliyon. 2024;10(15):e35265.","journal-title":"Heliyon"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04835-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04835-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04835-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:57:49Z","timestamp":1783468669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04835-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4835"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04835-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. It was approved by the IRB of Shanghai Pulmonary Hospital (approval number: FKYY2020-10; Chairperson: Lei Zhang) on June 25, 2021. All participants gave their written informed consent prior to study inclusion. The ethics committee waived additional requirements beyond the standard approval and informed consent procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form (including individual details, images, or videos). Therefore, consent for publication was not required. All reasonable measures have been taken to ensure patient anonymity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}